SCHEMBL29587371

SCHEMBL29587371

O=C1NCCc2c(F)cccc21

nearest known ligand 0.64

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 12/20 0.64
PARP10 Q53GL7 8/20 0.64
PARP11 Q9NR21 7/20 0.64
PDPK1 O15530 1/20 0.52
ACHE P22303 1/20 0.50
SRD5A1 P18405 1/20 0.47
PIM1 P11309 1/20 0.44
CSNK1A1 P48729 1/20 0.44
CDK5 Q00535 1/20 0.44
ROCK1 Q13464 1/20 0.44
DYRK1A Q13627 1/20 0.44
LRRK2 Q5S007 1/20 0.44
CLK4 Q9HAZ1 1/20 0.44
DYRK1B Q9Y463 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6421827 1.00 PARP1 (0.64) PARP1PARP10PARP11PDPK1ACHE
SCHEMBL29871952 0.81 CDK5 (0.61) PARP1PARP10PARP11SRD5A1PIM1
SCHEMBL1078443 0.81 CDK5 (0.61) PARP1PARP10PARP11SRD5A1PIM1
SCHEMBL797996 0.78 PARP1 (0.64) PARP1PARP10PARP11PDPK1ACHE
SCHEMBL21350834 0.78 SRD5A1 (0.41) PARP1PARP10PARP11PDPK1SRD5A1
SCHEMBL8118685 0.78 PARP1 (0.64) PARP1PARP10PARP11PDPK1ACHE
SCHEMBL5073463 0.78 PARP1 (0.64) PARP1PARP10PARP11PDPK1ACHE
SCHEMBL7581623 0.78 PARP1 (1.00) PARP1PARP10PARP11PDPK1ACHE
SCHEMBL830807 0.78 PARP1 (1.00) PARP1PARP10PARP11PDPK1ACHE
SCHEMBL4165821 0.78 ACHE (0.54) PARP1PARP10PARP11PDPK1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116507608-A Compounds, compositions, and methods 戴纳立制药公司 2023-07-28 CN disclosed
CN-109863145-B Novel tetrahydroisoquinoline and tetrahydronaphthyridine compounds for the treatment and prevention of hepatitis b virus infection 豪夫迈·罗氏有限公司 2022-04-12 CN disclosed